ALEMBIC PHARMACEUT chart

Last update: 2022-06-03
Key statistics and financials
Revenue per share 269.92
Dividend & Yield14.00₹ (1.91%)
Beta 0.73
Market capitalization 144.78B
Operating cash flow 5.52B
ESG Scores unknown

Company description

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (API) and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, anti-diabetic, gynecology, acute, gastroenterology, ophthalmology, dermatology, nephrology/urology, orthopedics, cancer, inflammation, autoimmune diseases, anti-infective, cold and cough, and metabolic disorders, as well as hospital care and animal health. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

Sector: Healthcare - Industry: Drug Manufacturers—Specialty & Generic

Financial data

Financial Statements

Cashflow Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Change To Liabilities -503.1M -211.1M 452.7M
Total Cashflows From Investing Activities -7.56B -7.32B -8.39B
Net Borrowings 2.21B 5.92B -12.58B
Total Cash From Financing Activities 590.4M 1.55B -5.97B
Change To Operating Activities 3.59B 68M -180.4M
Issuance Of Stock 7.34B 7.34B 7.34B
Net Income 5.84B 8.29B 11.78B
Change In Cash 1.15B -1.27B 262.2M
Effect Of Exchange Rate -700k 4.1M -9.3M
Total Cash From Operating Activities 8.12B 4.49B 14.63B
Depreciation 1.15B 1.57B 1.83B
Change To Account Receivables 361.9M -3.58B 5.11B
Other Cashflows From Financing Activities -862.1M -1.45B -730.4M
Change To Netincome 12.2M 562.6M -1.38B
Capital Expenditures -6.54B -7.35B -6.6B

Income Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Research Development
Income Before Tax 7.4B 10B 14B
Net Income 5.84B 8.29B 11.78B
Selling General Administrative 7.64B 9.09B 10.53B
Gross Profit 29.04B 35.15B 40.53B
Ebit 7.41B 11.11B 12.97B
Operating Income 7.41B 11.11B 12.97B
Interest Expense -184.1M -271.6M -160.2M
Income Tax Expense 1.57B 1.99B 2.53B
Total Revenue 39.35B 46.06B 53.93B
Cost Of Revenue 10.31B 10.9B 13.4B
Total Other Income ExpenseNet -12.8M -1.12B 1.03B
Net Income From Continuing Ops 5.83B 8.01B 11.46B
Net Income Applicable To Common Shares 5.84B 8.29B 11.78B

Balance Sheet Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Total Liabilities 20.6B 27.99B 16.42B
Total Stockholder Equity 27.19B 32.19B 51.28B
Other Current Liabilities 1.09B 1.29B 1.17B
Total Assets 47.78B 59.89B 67.09B
Common Stock 377M 377M 393.1M
Other Current Assets 2.84B 2.8B 4.06B
Retained Earnings 26.23B 30.75B 41.94B
Treasury Stock 577.6M 1.07B 1.46B
Cash 1.99B 718.4M 980.6M
Total Current Liabilities 14.9B 17.52B 12.81B
Other Stockholder Equity 577.6M 1.07B 1.46B
Property, Plant, and Equipment 24.4B 30.99B 36.48B
Total Current Assets 19.58B 24.63B 25.78B
Net Tangible Assets 24.49B 29.2B 48.05B
Net Receivables 4.89B 8.96B 3.65B
Accounts Payable 6.44B 6.26B 6.69B


Insider Transactions

Here are the insider transactions of stock shares related to ALEMBIC PHARMACEUT:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Alembic LtdAcquisition at price 9.69 per share.D2022-03-17Promoter38.71k
Shreno Ltd.I2022-03-08Promoter
Alembic LtdAcquisition at price 9.46 per share.D2022-03-04Promoter20k
Alembic LtdAcquisition at price 9.72 per share.D2022-03-03Promoter67.33k
Alembic LtdAcquisition at price 9.59 per share.D2022-02-28Promoter135k
Ramanbhai (Chirayu)Acquisition at price 10.61 per share.D2021-09-22Promoter100
Bhailal Amin General HospitalSale at price 12.95 per share.D2021-03-26Promoter200k
Uday Education SocietySale at price 12.88 per share.D2021-03-24Institution- Corporation200k
Alembic LtdAcquisition at price 12.89 per share.D2021-03-23Promoter284.98k
Bhailal Amin General HospitalSale at price 12.84 per share.D2021-03-23Promoter80.95k
Uday Education SocietySale at price 12.83 per share.D2021-03-23Promoter404.02k
Parikh (Maya Pranav)Acquisition at price 12.27 per share.D2021-02-22UNREPORTED575
Parikh (Salome)Acquisition at price 12.28 per share.D2021-02-22UNREPORTED575
Parikh (Maya Pranav)Acquisition at price 12.55 per share.D2021-02-19UNREPORTED550
Parikh (Salome)Acquisition at price 12.55 per share.D2021-02-19UNREPORTED550
Parikh (Shelina Pranav)Acquisition at price 12.55 per share.D2021-02-19UNREPORTED1.36k
Amin (Chirayu Ramanbhai)I2020-11-03Promoter
Amin (Pranav Chirayu)I2020-11-03Director (Executive)
Amin (Chirayu Ramanbhai)Acquisition at price 12.77 per share.D2020-11-02Executive Chairman3k
Amin (Chirayu Ramanbhai)Acquisition at price 12.98 per share.D2020-10-28Executive Chairman1.06M
Uday Education SocietySale at price 12.50 per share.D2020-09-08Promoter200k
Uday Education SocietySale at price 13.08 per share.D2020-09-04Promoter150k
Uday Education SocietySale at price 12.92 per share.D2020-08-31Promoter39.02k
Uday Education SocietySale at price 13.51 per share.D2020-08-28Promoter25k
Amin (Malika C)D2020-01-02Promoter3.01M
Amin (Pranav Chirayu)D2020-01-02Director (Executive)1.01M
Amin (Barkha Pranav)D2019-12-24Promoter100
Amin (Krupa Shaunak)D2019-12-24Promoter100
Shreno Ltd.D2019-12-24Promoter20.7M
Alembic City LtdD2019-09-25Promoter100
Gallup TrustD2019-09-25Promoter100
Grace Star TrustD2019-09-25Promoter100
Laksh TrustD2019-09-25Promoter100
Satori TrustD2019-09-25Promoter100
Shreno Publications LtdD2019-09-25Promoter100
Nirayu Pvt. LtdD2019-08-08Promoter56.32M
Arogyavardhini SocietyD2019-04-03Promoter280.95k
Bhailal Amin General HospitalD2019-04-03Promoter280.95k
Uday Education SocietyD2019-04-03Promoter1.02M
Ujjwal VidyalayaD2019-04-03Promoter62.25k
Utkarsh VidyakendraD2019-04-03Promoter146.25k
Vidyanidhi TrustD2019-04-03Promoter809.55k
Amin (Yeraben Ramanbhai)D2019-02-20UNREPORTED466
Amin (Yeraben Ramanbhai)D2019-02-19UNREPORTED1.53k
Alembic LtdD2019-02-12Promoter10k
Amin (Yeraben Ramanbhai)D2019-02-01UNREPORTED5k
Saraiya (Krupa Paresh)D2018-10-25Non-Independent Executive Director4.82k
Alembic LtdD2018-06-04Promoter15k
Patel (Jyoti Suresh)D2018-06-04UNREPORTED3k
Alembic LtdD2018-05-24Institution- Corporation1.53k
Alembic LtdD2018-05-21Promoter25k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to ALEMBIC PHARMACEUT. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on ALEMBIC PHARMACEUT

Here is the result of two systematic investment strategies applied to ALEMBIC PHARMACEUT. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on ALEMBIC PHARMACEUT

The following chart shows the equity curve of the two systematic investment strategies applied to ALEMBIC PHARMACEUT:

ALEMBIC PHARMACEUT automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 3.27% on the backtest period.

Performance at glance

Performance

3.27 %

Latent gain

238.45 ₹

Invested capital

7296.55 ₹

Annualized return

0.78 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on ALEMBIC PHARMACEUT

This is the result of two momentum investment strategies applied to ALEMBIC PHARMACEUT. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on ALEMBIC PHARMACEUT

The following chart shows all the entries opened by the momentum investment system on ALEMBIC PHARMACEUT:

ALEMBIC PHARMACEUT momentum entries
  • The first momentum investment strategy would give 14.11% of return on ALEMBIC PHARMACEUT. That represents 1304.2₹ of latent gain with 9244.8₹ of employed capital.
  • The second momentum investment strategy would give 10.44% of return on ALEMBIC PHARMACEUT. That represents 997.35₹ of latent gain with 9551.65₹ of employed capital.
Performance at glance (1Q Momentum)

Performance

14.11 %

Latent gain

1304.2 ₹

Invested capital

9244.8 ₹

Annualized return

-8.98 %
Performance at glance (2Q Momentum)

Performance

10.44 %

Latent gain

997.35 ₹

Invested capital

9551.65 ₹

Annualized return

2.81 %

Momentum equity curve on ALEMBIC PHARMACEUT

The following chart shows the equity curve of the two momentum strategies applied to ALEMBIC PHARMACEUT:

ALEMBIC PHARMACEUT momentum equity

Note: the dividends potentially given by ALEMBIC PHARMACEUT are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ALEMBIC PHARMACEUT

The following chart shows the employed capital evolution of the two momentum strategies on ALEMBIC PHARMACEUT since the beginning:

ALEMBIC PHARMACEUT

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250₹, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000₹.


Buy the dip strategy result on ALEMBIC PHARMACEUT

Buy the dip entry openings on ALEMBIC PHARMACEUT

ALEMBIC PHARMACEUT

The performance achieved by the robo-advisor on ALEMBIC PHARMACEUT is -19.76%. That represents -185.55$ of latent gain with 939.05₹ of employed capital. The following chart shows ALEMBIC PHARMACEUT stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of ALEMBIC PHARMACEUT, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

-19.76 %

Latent gain

-185.55 ₹

Invested capital

939.05 ₹

Annualized return

-8.98 %

Equity curve of the strategy applied to ALEMBIC PHARMACEUT

The following chart shows the result of the investment strategy applied to ALEMBIC PHARMACEUT:

ALEMBIC PHARMACEUT

Note: the dividends potentially given by ALEMBIC PHARMACEUT are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ALEMBIC PHARMACEUT

The following chart shows the employed capital evolution since the beginning of the investment strategy on ALEMBIC PHARMACEUT:

ALEMBIC PHARMACEUT

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on ALEMBIC PHARMACEUT

In this section, I will compare the three previous investment strategies applied to ALEMBIC PHARMACEUT.

Equity curve comparison on ALEMBIC PHARMACEUT

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

ALEMBIC PHARMACEUT investment strategy comparison

Employed capital comparison on ALEMBIC PHARMACEUT

ALEMBIC PHARMACEUT investment comparison

Performance comparison on ALEMBIC PHARMACEUT

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 3.27% 238.45₹ 7296.55₹ 0.78%
Momentum 1 quarter 14.11% 1304.2₹ 9244.8₹ 3.56%
Momentum 2 quarters 10.44% 997.35₹ 9551.65₹ 2.81%
Non-directional -19.76% -185.55₹ 939.05₹ -8.98%
Annualized return comparison

Automatic investment

0.78 %

Momentum 1Q

2.81 %

Momentum 2Q

2.81 %

Non-directional

-8.98 %

Correlated stocks

Here are the most positively and negatively correlated stocks with ALEMBIC PHARMACEUT:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between ALEMBIC PHARMACEUT and the other stocks. There may be false positives or some missing correlated stocks. If the price of ALEMBIC PHARMACEUT does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name ALEMBIC PHARMACEUT
Country India
City Vadodara
Address Alembic Road
Phone 91 26 5228 0550
Website www.alembicpharmaceuticals.com
FullTime employees
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Exchange XNSE
Ticker APLLTD.XNSE
Market

ALEMBIC PHARMACEUT ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown